{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:32:08Z","timestamp":1786739528733,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Antihistamines (AHs) are the most widely long-term therapeutic option to manage allergic diseases. This research aimed to study the effects of long-term administration of AHs: on cognitive (memory, mood, attention, sleep and executive function) and psychomotor performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      This prospective, observational study for a total duration of 30 months was carried out at the Dermatology OPD in adult patients with dermatological condition who were newly prescribed either chlorpheniramine (4 mg, BD), levocetirizine (10 mg, OD), fexofenadine (180 mg, OD) or bepotastine (10 mg, BD) for at least 28 days as per inclusion and exclusion criteria after taking written informed consent. A detailed history of the patients, memory (using PGI memory scale) and psychomotor functions, Brief Mood Introspection Scale and Epworth Sleepiness Scale were assessed at baseline, 1 week and 4 weeks. Data obtained were analysed using paired sample\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test and one-way ANOVA followed by post hoc analysis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value &lt;0.05 statistically significant).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 22 in chlorpheniramine group, 23 in levocetirizine group, 20 in fexofenadine group and 18 in bepotastine group were analysed. Chlorpheniramine and levocetirizine had deteriorating effects on cognitive and psychomotor performance, whereas fexofenadine and bepotastine showed positive effect on various cognitive and psychometric tasks. The study results showed chlorpheniramine and levocetirizine to be having sedative effects, whereas fexofenadine was nonsedating. In bepotastine group, no effect on sleep was observed. No significant difference in mood scores was observed in between chlorpheniramine, levocetirizine and fexofenadine groups. In bepotastine group, arousal calm and positive tired scores increased at 4 week as compared to baseline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Patients with dermatological illnesses can be prescribed fexofenedine and bepotastine, as compared to chlorpheniramine and levocetirizine, and their cognitive and psychological functions should be evaluated periodically with suitable tests.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_77_22","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T05:53:22Z","timestamp":1667973202000},"page":"5909-5917","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Old versus new antihistamines: Effects on cognition and psychomotor functions"],"prefix":"10.4103","volume":"11","author":[{"given":"K Sheth","family":"Shamil","sequence":"first","affiliation":[{"name":"Pediatric Resident Doctor, Michigan State University, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P Patel","family":"Prakruti","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, B.J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Gandhi","family":"Anuradha","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, B.J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Shah","family":"Bela","sequence":"additional","affiliation":[{"name":"Department of Skin and VD, B.J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Desai","family":"Chetna","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, B.J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"R1-20260527","doi-asserted-by":"crossref","first-page":"9","DOI":"10.9734\/BJPR\/2011\/223","article-title":"Drug utilization and cost analysis for common skin diseases in dermatology OPD of an Indian tertiary care hospital-A prescription survey","volume":"1","author":"Narwane","year":"2011","journal-title":"Br J Pharm Res"},{"key":"R2-20260527","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/ijd.IJD_325_17","article-title":"Awareness of family physicians towards antihistamines","volume":"64","author":"Zeerak","year":"2019","journal-title":"Indian J Dermatol"},{"key":"R4-20260527","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1939-4551-1-9-145","article-title":"H1 antihistamines:Current status and future directions","volume":"1","author":"Simon","year":"2008","journal-title":"World Allergy Organ J"},{"key":"R5-20260527","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5530\/jyp.2017.9.71","article-title":"Effect of antiepileptic drugs on psychomotor functions and memory in epilepsy patients","volume":"9","author":"Gupta","year":"2017","journal-title":"J Young Pharm"},{"key":"R7-20260527","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1037\/0022-3514.55.1.102","article-title":"The experience and meta-experience of mood","volume":"55","author":"Mayer","year":"1988","journal-title":"J Pers Soc Psychol"},{"key":"R8-20260527","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness:The Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"R9-20260527","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R10-20260527","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0970-2113.80343","article-title":"Adverse drug reaction and causality assessment scales","volume":"28","author":"Zaki","year":"2011","journal-title":"Lung India"},{"key":"R11-20260527","first-page":"538","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock","year":"1992","journal-title":"Hosp Pharm"},{"key":"R12-20260527","first-page":"2229","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"Hartwig","year":"1992","journal-title":"Am J Hosp Pharm"},{"key":"R13-20260527","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/aian.AIAN_107_17","article-title":"Status of cognitive testing of adults in India","volume":"20","author":"Porrselvi","year":"2017","journal-title":"Ann Indian Acad Neurol"},{"key":"R14-20260527","doi-asserted-by":"crossref","first-page":"1216242","DOI":"10.1080\/23311908.2016.1216242","article-title":"Antihistamines considerably modulate the cognitive and psychomotor performance of human volunteers","volume":"3","author":"Zannat","year":"2016","journal-title":"Cognet Psychology"},{"key":"R15-20260527","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0447.1998.tb05972.x","article-title":"Cognition and anxiety:The cognitive effects of anti-anxiety medication","volume":"98","author":"Hindmarch","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"R16-20260527","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2125.2002.01611.x","article-title":"Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers","volume":"54","author":"Gandon","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"R17-20260527","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bjp.0702994","article-title":"Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine","volume":"129","author":"Okamura","year":"2000","journal-title":"Br J Pharmacol"},{"key":"R18-20260527","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0091-6749(94)90179-1","article-title":"Sleepiness and performance during three-day administration of cetirizine or diphenhydramine","volume":"94","author":"Schweitzer","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"R19-20260527","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00981126","article-title":"Acute and subacute actions on human performance and interactions with diazepam of temelastine (SK &F 93944) and diphenhydramine","volume":"31","author":"Mattila","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"R20-20260527","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1067\/mai.2003.63","article-title":"Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood","volume":"111","author":"Verster","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R21-20260527","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1476-5381.2010.00907.x","article-title":"Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory","volume":"161","author":"Van Ruitenbeek","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R22-20260527","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejphar.2004.11.017","article-title":"Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties","volume":"506","author":"Lapa","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R23-20260527","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejphar.2012.03.003","article-title":"Effects of the histamine H1 receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward","volume":"683","author":"Oleson","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"R24-20260527","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3940(02)00050-2","article-title":"Histamine excites GABAergic cells in the rat substantia nigra and ventral tegmental area in vitro","volume":"320","author":"Korotkova","year":"2002","journal-title":"Neurosci Lett"},{"key":"R25-20260527","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjp.2008.147","article-title":"The histamine H3 receptor:An attractive target for the treatment of cognitive disorders","volume":"154","author":"Esbenshade","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R26-20260527","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0019-5154.110832","article-title":"Pharmacology of antihistamines","volume":"58","author":"Church","year":"2013","journal-title":"Indian J Dermatol"},{"key":"R27-20260527","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0091-6749(05)80225-8","article-title":"Performance effects of antihistamines","volume":"86","author":"Meltzer","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"R28-20260527","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/0091270004267590","article-title":"Central effects of fexofenadine and cetirizine:Measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography","volume":"44","author":"Tashiro","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"R29-20260527","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40265-016-0682-0","article-title":"Sedative effects of levocetirizine:A systematic review and meta-analysis of randomized controlled studies","volume":"77","author":"Snidvongs","year":"2017","journal-title":"Drugs"},{"key":"R30-20260527","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2230.2004.01618.x","article-title":"Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance","volume":"29","author":"Takahashi","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"R31-20260527","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/13651501.2014.907919","article-title":"Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety","volume":"18","author":"Ozdemir","year":"2014","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R32-20260527","first-page":"305","article-title":"Efficacy and safety of levocetirizine in seasonal allergic rhinitis","volume":"55","author":"Leynadier","year":"2001","journal-title":"Acta Otorhinolaryngol Belg"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_77_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:29:44Z","timestamp":1786735784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_77_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_77_22","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"2022-01-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}